Ono Pharmaceutical Co. (OPHLF)
(Delayed Data from OTC)
$15.96 USD
0.00 (0.00%)
Updated Apr 9, 2024 09:46 AM ET
4-Sell of 5 4
C Value B Growth B Momentum B VGM
Price, Consensus and EPS Surprise
OPHLF 15.96 0.00(0.00%)
Will OPHLF be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OPHLF based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for OPHLF
Ono Pharmaceutical Co. (OPHLF) Upgraded to Buy: Here's Why
New Strong Sell Stocks for June 2nd
OPHLF: What are Zacks experts saying now?
Zacks Private Portfolio Services
3 Reasons Why Ono Pharmaceutical Co. (OPHLF) Is a Great Growth Stock
Ono Pharmaceutical Co. (OPHLF) Upgraded to Strong Buy: What Does It Mean for the Stock?
Has Acadia Healthcare (ACHC) Outpaced Other Medical Stocks This Year?
Other News for OPHLF
Equillium Inc and Ono Pharmaceutical Co Ltd to Announce Exclusive Option and Asset Purchase ...
Ono Pharmaceutical GAAP EPS of ¥229.06, revenue of ¥389.91B
Merus Stock: Rally Seems Overdone